Functional constraints on the constitutive androstane receptor inferred from human sequence variation and

Emma E Thompson1, Hala Kuttab-Boulos, Matthew D Krasowski

  • 1Committee on Genetics, University of Chicago, Chicago, IL 60637, USA.

Human Genomics
|October 4, 2005
PubMed

Insights

Genetic variations in the constitutive androstane receptor (CAR) gene show limited interethnic differences, suggesting other factors influence drug metabolism. Conserved non-coding variants may impact CAR gene expression and drug response.

Area of Science:

  • Pharmacogenomics
  • Molecular biology
  • Genetics

Background:

  • Nuclear receptors, including NR1I3 (constitutive androstane receptor or CAR), regulate genes vital for drug metabolism and transport.
  • Significant inter-individual variability exists in drug clearance, partly due to genetic factors influencing drug-metabolizing enzymes like CYP3A, CYP2B, and UGT1A.
  • Genetic variations within the CAR locus could explain differences in gene expression and drug response.

Purpose of the Study:

  • To investigate sequence variation in the CAR gene across different populations.
  • To determine if genetic variations in CAR contribute to interethnic differences in drug metabolism.
  • To identify potential regulatory variants affecting CAR expression.

Main Methods:

  • Comparative genomics was used to select resequencing regions in 70 individuals from three distinct populations.
  • DNA sequencing was performed to identify polymorphic sites within the CAR gene.
  • Phylogenetic analysis was employed to assess the conservation of identified variants.

Main Results:

  • Twenty-one polymorphic sites were identified in the CAR gene, with one leading to an amino acid substitution.
  • A common haplotype, highly similar to the ancestral sequence, was found across all populations, indicating strong functional constraints on CAR.
  • Sequence variation patterns were similar across populations, suggesting CAR genetic variation is not a primary driver of interethnic drug metabolism differences.
  • Several conserved non-coding variants were identified, potentially influencing CAR expression.

Conclusions:

  • Genetic variation at the CAR locus does not appear to be a major cause of interethnic differences in drug metabolism.
  • Conserved non-coding variants in the CAR gene may play a role in regulating its expression and downstream drug-metabolizing enzyme activity.
  • Further research into these non-coding variants could provide insights into personalized medicine and drug response variability.

Related Concept Videos

Conserved Binding Sites01:49

Conserved Binding Sites

Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally analyses the...
Ligand Binding and Linkage00:49

Ligand Binding and Linkage

Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked.  In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence the...
Cis-regulatory Sequences02:02

Cis-regulatory Sequences

Cis-regulatory sequences are short fragments of non-coding DNA that are present on the same chromosomes as the genes that they regulate. These fragments serve as binding sites for transcriptional regulators, proteins that are responsible for controlling gene transcription and differential gene expression across cell types in eukaryotes. Cis-regulatory sequences can be close to the gene of interest or thousands of bases away in the DNA sequence; however, those sequences that are further away are...
The Two-State Receptor Model01:29

The Two-State Receptor Model

The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with one...
Allosteric Proteins-ATCase01:19

Allosteric Proteins-ATCase

Binding sites linkages can regulate a protein's function.  For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to  N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Cell Signaling in Plants01:25

Cell Signaling in Plants

Plant cells communicate to coordinate their cycle of growth, flowering and fruiting, and activities in roots, shoots, and leaves in response to the changing environmental conditions. Plant signaling is distinct from animal signaling. Plants primarily utilize enzyme-linked receptors, whereas the largest class of cell-surface receptors in animals are G-protein coupled receptors (GPCRs). Unlike animals, receptor tyrosine kinases are rare in plants. Instead, plants have a diverse class of...